Clinical Trial Update: A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating standard treatment with or without enoxaparin in small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Lund University Hospital | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED